Understanding joint bleeding in people with hemophilia
Exploring the Biomechanics of Joint Bleeding in Persons with Hemophilia to Better
['FUNDING_OTHER'] · UNIVERSITY OF COLORADO DENVER · NIH-11005040
This study looks at how bleeding in the joints affects how people with hemophilia move, using special technology to measure their movements, so we can help them make safer choices for staying active and reduce the chances of future bleeding.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF COLORADO DENVER (nih funded) |
| Locations | 1 site (Aurora, UNITED STATES) |
| Trial ID | NIH-11005040 on ClinicalTrials.gov |
What this research studies
This research investigates how joint bleeding affects movement and biomechanics in individuals with hemophilia. By using advanced motion capture and force plate technology, the study aims to objectively measure the forces involved in lower extremity joint and muscle bleeding. The goal is to better understand the relationship between past joint bleeding and current movement patterns, which could help inform safer physical activity choices for patients. Ultimately, this research seeks to reduce the risk of future bleeding episodes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hemophilia who experience joint bleeding.
Not a fit: Patients without a diagnosis of hemophilia or those who do not experience joint bleeding may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing joint bleeding and enhancing the quality of life for individuals with hemophilia.
How similar studies have performed: Previous research has shown promise in understanding biomechanics related to bleeding disorders, but this specific approach is relatively novel.
Where this research is happening
Aurora, UNITED STATES
- UNIVERSITY OF COLORADO DENVER — Aurora, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WARREN, BETH BOULDEN — UNIVERSITY OF COLORADO DENVER
- Study coordinator: WARREN, BETH BOULDEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.